Trade

with

Tonix Pharmaceuticals Holding Corp
(NASDAQ: TNXP)
AdChoices
6.24
+0.48
+8.33%
After Hours :
-
-
-

Open

5.80

Previous Close

5.76

Volume (Avg)

72.39k (150.95k)

Day's Range

5.71-6.36

52Wk Range

3.61-21.00

Market Cap.

61.00M

Dividend Rate ( Yield )

-

Beta

4.39

Shares Outstanding

10.59M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Drug Manufacturers – Major
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 0

    • Net Income

    • -10.88M

    • Market Cap.

    • 61.00M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 4.39

    • Forward P/E

    • -2.06

    • Price/Sales

    • -

    • Price/Book Value

    • 1.43

    • Price/Cash flow

    • -2.43

      • EBITDA

      • -10.87M

      • Return on Capital %

      • -79.35

      • Return on Equity %

      • -88.48

      • Return on Assets %

      • -79.35

      • Book Value/Share

      • 4.03

      • Shares Outstanding

      • 10.59M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 17.00

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • -2.80

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 0.00

          • 0.89

          • Net Income

            YTD/YTD (last year)

          • -

          • 7.80

          • Net Income

            Q/Q (last year)

          • -

          • 4.50

          • Sales (Revenue)

            5-Year Annual Average

          • 0.00

          • 6.10

          • Net Income

            5-Year Annual Average

          • -

          • 3.73

          • Dividends

            5-Year Annual Average

          • -

          • 2.17

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • -

            • 69.92

            • Pre-Tax Margin

            • -

            • 21.84

            • Net Profit Margin

            • -

            • 18.37

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 71.90

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 21.92

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 903.40B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.32

              • Current Ratio

              • 18.90

              • 1.92

              • Quick Ratio

              • 18.50

              • 1.31

              • Interest Coverage

              • -

              • 17.64

              • Leverage Ratio

              • 1.06

              • 2.03

              • Book Value/Share

              • 4.03

              • 14.72

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -2.18

                • 21.88

                • P/E Ratio 5-Year High

                • -15.58

                • 193.96

                • P/E Ratio 5-Year Low

                • -0.85

                • 87.26

                • Price/Sales Ratio

                • -

                • 3.70

                • Price/Book Value

                • 1.43

                • 3.69

                • Price/Cash Flow Ratio

                • -2.43

                • 13.85

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -88.48

                        (-)

                      • 17.42

                        (18.66)

                      • Return on Assets %

                        (5-Year Average)

                      • -79.35

                        (-572.60)

                      • 8.45

                        (8.77)

                      • Return on Capital %

                        (5-Year Average)

                      • -88.48

                        (-)

                      • 12.41

                        (13.18)

                      • Income/Employee

                      • -

                      • 90.07k

                      • Inventory Turnover

                      • -

                      • 2.46

                      • Asset Turnover

                      • -

                      • 0.46

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -10.89M
                      Operating Margin
                      -
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -2.43
                      Ownership

                      Institutional Ownership

                      30.14%

                      Top 10 Institutions

                      33.33%

                      Mutual Fund Ownership

                      7.36%

                      Float

                      91.89%

                      5% / Insider Ownership

                      42.64%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Franklin Biotechnology Discovery

                      •  

                        309,300

                      • 49.35

                      • 3.12

                      • Franklin Biotechnology Discovery Fund

                      •  

                        160,181

                      • -2.44

                      • 1.51

                      • Vanguard Total Stock Mkt Idx

                      •  

                        149,365

                      • 0.00

                      • 1.41

                      • Vanguard Extended Market Index Fund

                      •  

                        82,395

                      • 0.00

                      • 0.78

                      • TFS Market Neutral Fund

                      •  

                        35,787

                      • 25.15

                      • 0.36

                      • iShares Micro-Cap

                      •  

                        27,115

                      • 1.28

                      • 0.20

                      • PowerShares Zacks Micro Cap Portfolio

                      •  

                        12,119

                      • 0.00

                      • 0.09

                      • Vanguard Balanced Index Fund

                      •  

                        5,300

                      • 0.00

                      • 0.05

                      • AXA/Lord Abbett Micro Cap Portfolio

                      •  

                        1,842

                      • 5.20

                      • 0.02

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Franklin Advisers, Inc.

                      •  

                        473,481

                      • 0.00%

                      • 4.77

                      • Broadfin Capital, LLC

                      •  

                        467,639

                      • 0.00%

                      • 4.71

                      • Kingdon Capital Management LLC

                      •  

                        275,000

                      • 0.00%

                      • 2.76

                      • Bluestein R H & Co

                      •  

                        255,250

                      • -10.78%

                      • 2.57

                      • Lombard Odier Asset Management USA Corp

                      •  

                        225,000

                      • -6.05%

                      • 2.27

                      • Wall Street Associates Llc

                      •  

                        200,000

                      • 0.00%

                      • 2.01

                      • Vanguard Group, Inc.

                      •  

                        199,913

                      • +2.78%

                      • 2.01

                      • Sabby Management LLC

                      •  

                        187,894

                      • -31.67%

                      • 1.89

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Drug Manufacturers – Major

                      Type

                      Distressed

                      Style

                      -

                      Tonix Pharmaceuticals Holding Corp was incorporated on November 16, 2007 under the laws of the State of Nevada as Tamandare Explorations Inc. On October 11, 2011, the Company changed the name to Tonix Pharmaceuticals Holding Corp. It...more is a pharmaceutical company dedicated to the development of novel pharmaceutical products for challenging problems. Its drug development programs are directed toward CNS conditions that manifest with pain that originates in the brain, or central pain. Its product candidate, TNX-102 sublingual tablet, or TNX-102 SL, is a small, rapidly disintegrating tablet containing CBP for sublingual administration. It has conducted several clinical and non-clinical pharmacokinetic studies of TNX-102 sublingual formulations, which supports the development of TNX-102 SL as a novel ther...moreapeutic product for FM and PTSD. The Company competes with pharmaceutical and biotechnology companies, specialty pharmaceutical and generic drug companies, academic institutions, government agencies and research institutions. Product candidates employing Company’s technology is subject to extensive and rigorous domestic government regulation including regulation by the FDA, the Centers for Medicare and Medicaid Services, other divisions of the United States Department of Health and Human Services, the United States Department of Justice, state and local governments, and their respective foreign equivalents.lessless

                      Key People

                      Dr. Seth Lederman

                      CEO/Chairman of the Board/President

                      Dr. Leland Gershell

                      CFO/Chief Accounting Officer/Treasurer

                      John B. Rhodes

                      Director

                      Patrick P. Grace

                      Director

                      Dr. Ernest Mario,PhD

                      Director

                      • Tonix Pharmaceuticals Holding Corp

                      • 509 Madison Avenue

                      • New York, NY 10022

                      • USA.Map

                      • Phone: +1 212 980-9155

                      • Fax: +1 212 923-5700

                      • tonixpharma.com

                      Incorporated

                      2007

                      Employees

                      6

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: